Promising results in sleep apnea pill could eliminate patient need for uncomfortable CPAP machine - Leaving obstructive sleep ...

The first-ever sleep apnea pill cut breathing episodes by over 50% in Phase 3 trials. Here's the data and when to expect FDA ...

Resmed has closed its $340 million acquisition of Noctrix Health, picking up a wearable neuromodulation device that pushes ...

Alesis LLC today announced the addition of three new joint venture locations to the Alesis Apnea Network in a single week: ...

Athens-Limestone Hospital introduces the FDA-approved Genio system to North Alabama, offering innovative nerve stimulation ...

Getting adequate sleep affects more than just energy levels—research suggests it also plays a major role in memory, cognition ...

As a man who can’t stay awake for the 11 o’clock news, which isn’t worth watching anyway, I tire easily. Then I fall asleep.

That CPAP machine? It tells your insurance company whether you used it enough. And it’s not the only device in your house ...

Paul Rosenberger details the use of noninvasive and invasive airway management and six medications to treat respiratory ...

A LM is a safe alternative to TT intubation for pediatric patients with obstructive sleep apnea undergoing adenotonsillectomies.

ResMed (RMD) outlines growth catalysts in sleep & breathing health: AI, wearables, GLP-1 tailwinds, COPD, and Noctrix RLS deal—read key takeaways now.

Determined not to write about serious topics like local elections, this hopefully will be both amusing and informative.